Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Platzer fastigheter in connection with the detailed development plan for Södra Änggården entering into force.
Mandate

Vinge has advised Platzer fastigheter in connection with the detailed development plan for Södra Änggården entering into force.

April 08, 2022 Real Estate and Construction

On 6 April 2022, the detailed development plan for Södra Änggården entered into force. The Swedish Supreme Land and Environmental Court has refused permission to appeal in respect of the detailed development plan for the transformation of Högsbo industrial area to the mixed use urban area Södra Änggården. The judgment may not be appealed.

The detailed development plan enables the building of, inter alia, approximately 1,900 residences as well as business premises, schools and parks. Platzer is the biggest property owner in the area today. The total income for Platzer is estimated to be approximately SEK 1.8 billion.

Amongst other issues, Vinge’s role in the matter has been to appear for Platzer in the Swedish Supreme Land and Environmental Court.

Vinge’s team primarily consisted of Robert Deli and Hampus Wahlberg.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025